Pfizer to provide Ibrance for free during NICE analysis; the FDA approves new ALS drug; people turn to Twitter to tell stories about pre-existing conditions
If CSL Limited CEO Paul Perreault sneezes, Australia gets a cold
Anthem and Cigna accuse each other of violating merger terms; Alzheimer’s experimental drug fails late-stage study; study calls for new approach to eradicate global epidemics
Reimbursement rather than Brexit more likely to impact how drugmakers order global launches